Primary pulmonary lymphoepithelioma-like carcinoma treated with immunotherapy: A case report and literature review

Simple item page
dc.contributor.authorArchwamety A.
dc.contributor.authorRuangchira-urai R.
dc.contributor.authorAkewanlop C.
dc.contributor.authorKorphaisarn K.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:45:03Z
dc.date.available2023-06-18T17:45:03Z
dc.date.issued2022-09-01
dc.description.abstractHere, we report a case of metastatic Epstein–Barr virus (EBV)-related primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) in a young, nonsmoking female who responded well to treatment with two types of immune checkpoint inhibitors (ICIs). This is the first case report of a favorable outcome to ICIs in the late-line treatment of advanced PPLELC patients with programmed cell death-ligand 1 (PD-L1) expression.
dc.identifier.citationThoracic Cancer Vol.13 No.17 (2022) , 2539-2541
dc.identifier.doi10.1111/1759-7714.14580
dc.identifier.eissn17597714
dc.identifier.issn17597706
dc.identifier.pmid35830974
dc.identifier.scopus2-s2.0-85133903448
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85600
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titlePrimary pulmonary lymphoepithelioma-like carcinoma treated with immunotherapy: A case report and literature review
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133903448&origin=inward
oaire.citation.endPage2541
oaire.citation.issue17
oaire.citation.startPage2539
oaire.citation.titleThoracic Cancer
oaire.citation.volume13
oairecerif.author.affiliationSiriraj Hospital

Files

Collections

Scopus 2022